Skip to main content

Loading market ticker...

Gland Pharma

Healthcare NSE:GLAND

1713.50INR
-81.90 ( -4.56%)

Last update at April 24, 2026, midnight

Day Range

1702.901798.10
LowHigh

52 Week Range

1266.01 2111.33
LowHigh

Fundamentals

  • Previous Close 1795.40
  • Market Cap 281733.46M
  • Volume161,904
  • P/E Ratio 35.62
  • EBITDA 13515.98M
  • Revenue TTM 58014.58M
  • Revenue Per Share TTM 352.18
  • Gross Profit TTM 34001.71M
  • Diluted EPS TTM 48.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 10626.58M 11325.42M 10545.82M 16185.52M 13348.10M
Net income 6985.26M 7724.60M 7810.43M 12116.64M 9969.63M
Total Revenue 56165.04M 56647.22M 36246.01M 43841.45M 34236.37M
Gross Profit 31543.74M 31108.10M 19391.74M 22749.28M 19317.63M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 112249.20M 106612.46M 87775.35M 78336.21M 64960.82M
Intangible assets 1057.02M 1122.19M 116.61M 125.35M 125.35M
Other current assets 6289.93M 3818.61M 2477.79M 1722.29M 1292.91M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 21991.21M -15518.07M 15900.75M -1736.43M 3229.66M
Operating Cash 9147.30M 9967.97M 3639.68M 7907.69M 6049.29M
Free Cash Flow 5301.88M 6068.67M 1408.49M 2686.50M 3761.53M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
GLAND
Gland Pharma 		-81.90 -4.56% 1713.50 281733.46 35.62
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-59.70 -3.55% 1620.40 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-17.00 -0.27% 6361.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-30.00 -0.72% 4117.20 1362716.66 63.48
CIPLA
Cipla Limited 		-10.90 -0.83% 1295.00 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.